Robin Marsden

Ms. Marsden has over 25 years of experience in biotechnology, which has included executing the successful bioanalytical and immunogenicity strategy supporting three FDA-approved products: Symlin and Byetta (both, Astra-Zeneca (previously Amylin)), and Giapreza (La Jolla Pharmaceutical). Robin’s experience includes drug development for a wide variety of molecules including biotherapeutics, peptides, small molecules, PEGylated therapeutics, and antibody drug conjugates (ADCs). Most recently, in her role as Senior Director of La Jolla Pharmaceutical, Robin oversaw a team of twelve research associates and scientists, all responsible for preclinical, bioanalytical, and biologics disciplines supporting multiple La Jolla programs. Currently, Robin is supporting all R&D related activities at Revelation Biosciences, including providing scientific rationale to support corporate strategy, writing patents and regulatory submissions, and overseeing outsourced activities. Robin earned her Bachelor of Sciences degree in Biology from San Diego State University.